These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 28260080)
1. Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer. Luo P; Lu G; Fan LL; Zhong X; Yang H; Xie R; Lv Z; Lv QZ; Fu D; Yang LX; Ma Y Oncol Rep; 2017 Apr; 37(4):2057-2062. PubMed ID: 28260080 [TBL] [Abstract][Full Text] [Related]
2. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival. Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348 [TBL] [Abstract][Full Text] [Related]
3. TMPRSS3 is a novel poor prognostic factor for breast cancer. Rui X; Li Y; Jin F; Li F Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247 [TBL] [Abstract][Full Text] [Related]
4. A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation. Guerrero K; Wang Z; Bachvarova M; Gregoire J; Renaud MC; Plante M; Bachvarov D Gynecol Oncol; 2012 Jun; 125(3):720-6. PubMed ID: 22446619 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of the transmembrane protease serine 3 mRNA level in radioresistant colorectal cancer tissues. Wen JY; Fang YY; Chen G; He RQ; Huang HQ; Wang RS; Zeng DT; Huang WJ; Qin XG Biomark Med; 2022 Jun; 16(9):693-715. PubMed ID: 35543030 [No Abstract] [Full Text] [Related]
6. Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma. Cheng MF; Lin LH; Huang MS; Lee HS; Ji DD; Lin CS; Hsia KT Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):481-488. PubMed ID: 26862950 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of TMPRSS4 expression in patients with breast cancer. Liang B; Wu M; Bu Y; Zhao A; Xie F Med Oncol; 2013 Jun; 30(2):497. PubMed ID: 23420063 [TBL] [Abstract][Full Text] [Related]
9. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer. Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302 [TBL] [Abstract][Full Text] [Related]
10. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis. Zhang D; Qiu S; Wang Q; Zheng J Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker. Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119 [TBL] [Abstract][Full Text] [Related]
12. The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer. Sawasaki T; Shigemasa K; Gu L; Beard JB; O'Brien TJ Tumour Biol; 2004; 25(3):141-8. PubMed ID: 15361711 [TBL] [Abstract][Full Text] [Related]
13. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Bleckmann A; Conradi LC; Menck K; Schmick NA; Schubert A; Rietkötter E; Arackal J; Middel P; Schambony A; Liersch T; Homayounfar K; Beißbarth T; Klemm F; Binder C; Pukrop T Clin Exp Metastasis; 2016 Apr; 33(4):309-23. PubMed ID: 26862065 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ubiquilin1 expression in invasive breast cancer. Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952 [TBL] [Abstract][Full Text] [Related]
15. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer. Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481 [TBL] [Abstract][Full Text] [Related]
16. The clinical and prognostic significance of midkine in breast cancer patients. Li F; Tian P; Zhang J; Kou C Tumour Biol; 2015 Dec; 36(12):9789-94. PubMed ID: 26159850 [TBL] [Abstract][Full Text] [Related]
17. Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer. Teschendorff AE; Li L; Yang Z Genome Biol; 2015 Apr; 16(1):61. PubMed ID: 25886003 [TBL] [Abstract][Full Text] [Related]
18. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer. Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer. Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935 [TBL] [Abstract][Full Text] [Related]
20. The SIRT 3 expression profile is associated with pathological and clinical outcomes in human breast cancer patients. He S; He C; Yuan H; Xiong S; Xiao Z; Chen L Cell Physiol Biochem; 2014; 34(6):2061-9. PubMed ID: 25562154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]